Search

Search Constraints

You searched for: Author/Creator Edge, Colin

Search Results

1. Discovery of 5-substituent-N-arylbenzamide derivatives as potent, selective and orally bioavailable LRRK2 inhibitors. Issue 17 (1st September 2017)

2. Discovery of 4-ethoxy-7H-pyrrolo[2, 3-d]pyrimidin-2-amines as potent, selective and orally bioavailable LRRK2 inhibitors. Issue 9 (15th May 2018)

4. A High-Throughput Screen to Identify LRRK2 Kinase Inhibitors for the Treatment of Parkinson's Disease Using RapidFire Mass Spectrometry. (February 2016)

5. 5-Substituted-N-pyridazinylbenzamides as potent and selective LRRK2 inhibitors: Improved brain unbound fraction enables efficacy. Issue 2 (15th January 2019)